Omentectomy in addition to gastric bypass surgery and influence on insulin sensitivity: A randomized double blind controlled trial

Clinical Nutrition

Volumn 33, Issue 6, 2014, Pages 991-996

  Andersson, Daniel P ^a   Thorell, Anders ^b   Löfgren, Patrik ^a   Wirén, Mikael ^a   Toft, Eva ^b   Qvisth, Veronica ^b   Riserus, Ulf ^c   Berglund, Lars ^c   Näslund, Erik ^d   Bringman, Sven ^e   Thörne, Anders ^e   Arner, Peter ^a   Hoffstedt, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

^e Division of Obstetrics and Gynecology Södertälje Hospital   (Sweden)

Author keywords

Bariatric surgery; Hyperinsulinemic euglycemic clamp; Insulin sensitivity; Omentectomy; Weight loss

Indexed keywords

ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY WEIGHT; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTECTOMY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION; BODY MASS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; OMENTUM; PROCEDURES; RISK FACTOR; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; GASTRIC BYPASS; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY; OMENTUM; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84920160911     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.01.004     Document Type: Article

References (20)

1. Matsuzawa Y. Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci 2010, 86(2):131-141. e-pub ahead of print 2010/02/16.
2. Neeland I.J., Turer A.T., Ayers C.R., Powell-Wiley T.M., Vega G.L., Farzaneh-Far R., et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012, 308(11):1150-1159. e-pub ahead of print 2012/09/20. 10.1001/2012.jama.11132.
3. Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990, 10(4):493-496. e-pub ahead of print 1990/07/01.
4. Arner P. Not all fat is alike. Lancet 1998, 351(9112):1301-1302. e-pub ahead of print 1998/06/27. 10.1016/S0140-6736(05)79052-8.
5. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004, 24(1):29-33. e-pub ahead of print 2003/10/11. 10.1161/01.ATV.0000099786.99623.EF.
6. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R.S., et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002, 51(6):1884-1888. e-pub ahead of print 2002/05/29.
7. Thorne A., Lonnqvist F., Apelman J., Hellers G., Arner P. Apilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002, 26(2):193-199. e-pub ahead of print 2002/02/19. 10.1038/sj.ijo.0801871.
8. Lee K., Lee S., Kim Y.J. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition 2008, 24(7-8):625-631. e-pub ahead of print 2008/05/20 pii:S0899-9007(08)00131-7. 10.1016/j.nut.2008.03.004.
9. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502. e-pub ahead of print 1972/06/01.
10. Wahrenberg H., Hertel K., Leijonhufvud B.M., Persson L.G., Toft E., Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 2005, 330(7504):1363-1364. e-pub ahead of print 2005/04/19 pii:bmj.38429.473310.AE. 10.1136/bmj.38429.473310.AE.
11. Dirksen C., Jorgensen N.B., Bojsen-Moller K.N., Jacobsen S.H., Hansen D.L., Worm D., et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012, 55(7):1890-1901. e-pub ahead of print 2012/04/28. 10.1007/s00125-012-2556-7.
12. Van Harmelen V., Lonnqvist F., Thorne A., Wennlund A., Large V., Reynisdottir S., et al. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord 1997, 21(11):972-979. e-pub ahead of print 1997/11/22.
13. Fabbrini E., Tamboli R.A., Magkos F., Marks-Shulman P.A., Eckhauser A.W., Richards W.O., et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 2010, 139(2):448-455. e-pub ahead of print 2010/05/12. 10.1053/j.gastro.2010.04.056.
14. Dunn J.P., Abumrad N.N., Breitman I., Marks-Shulman P.A., Flynn C.R., Jabbour K., et al. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care 2012, 35(1):137-142. e-pub ahead of print 2011/11/02. 10.2337/dc11-1383.
15. Dillard T.H., Purnell J.Q., Smith M.D., Raum W., Hong D., Laut J., et al. Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial. Surg Obes Relat Dis 2011, e-pub ahead of print 2011/11/29. 10.1016/j.soard.2011.09.027.
16. Lima M.M., Pareja J.C., Alegre S.M., Geloneze S.R., Kahn S.E., Astiarraga B.D., et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study withthe euglycemic-hyperinsulinemic clamp. JClin Endocrinol Metab 2010, 95(8):3871-3875. e-pub ahead of print 2010/05/21. 10.1210/jc.2010-0085.
17. Lima M.M., Pareja J.C., Alegre S.M., Geloneze S.R., Kahn S.E., Astiarraga B.D., et al. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring) 2013, 21(3):E182-E189. e-pub ahead of print 2013/02/14. 10.1002/oby.20030.
18. Csendes A., Maluenda F., Burgos A.M. Aprospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy. Obes Surg 2009, 19(4):490-494. e-pub ahead of print 2008/08/21. 10.1007/s11695-008-9660-2.
19. Herrera M.F., Pantoja J.P., Velazquez-Fernandez D., Cabiedes J., Aguilar-Salinas C., Garcia-Garcia E., et al. Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial. Diabetes Care 2010, 33(7):1413-1418. e-pub ahead of print 2010/07/01. 10.2337/dc09-1833.
20. Forse R.A. Comment on: omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial. Surg Obes Relat Dis 2011, e-pub ahead of print 2011/12/16. 10.1016/j.soard.2011.11.002.